SAB Biotherapeutics Inc (SABS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
SAB Biotherapeutics chiqarilishlarni tezlashtirish uchun robotlashtirilgan skrining va dasturiy ma'lumotlar tahlili avtomatlashtirishini joriy qilmoqda. Kompaniya AQSh hukumat agentliklari bilan hamkorlikda antiviral antitanalarni ishlab chiqadi. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasi 0.02 darajasida barqarorlashdi va donor materiallarisiz poliklonal dori vositalarini sintez qilish uchun DiversitAb platformasidan foydalanadigan ushbu bioinzheneriya yetakchisining rivojlanish profilini yakunladi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_SABS_-_SAB-Biotherapeutics_-_Long-Term-Debt-to-Capital "SABS: SAB Biotherapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
SAB Biotherapeutics (SABS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati sabbiotherapeutics.com|SABS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati SAB Biotherapeutics, Inc.|SABS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi SAB Biotherapeutics|Tezkor likvidlik ko‘rsatkichi sabbiotherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:SAB Biotherapeutics Inc. - SABS
Operatsion samaradorlik moliyalashtirish tuzilmasining barqarorligiga bevosita ta'sir qiladi. Ushbu ko'rsatkich moliyaviy leverajni baholash uchun uzoq muddatli majburiyatlarning kapitalga nisbatan ulushini o'lchaydi. SAB Biotherapeutics (SABS) uchun ushbu muvozanat antitelalarni ishlab chiqish bo'yicha davlat dasturlarini amalga oshirishda juda muhimdir. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish innovatsiyalar uchun mablag'lar yetishmasligi xatarlarini baholash imkonini beradi. Uzoq muddatli qarzning kapitalga nisbatining tarixiy tendentsiyasi qarz mablag'larini boshqarish strategiyasini aniq namoyish etadi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Pieris Corp PVLA|SVRA: Uzoq muddatli qarzning kapitalga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ventyx Biosciences, Inc (VTYX)|Uzoq muddatli qarzning o'z kapitaliga nisbati THTX|AVTX (avalotx.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ELDN|AGEN (Agenus, Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|zurabio.com (ZURA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ATYR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADAG (Adagene)|IMA: Uzoq muddatli qarzning kapitalga nisbati|Shattuck Labs (STTK) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium Inc|Connect Pharma - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IMUX|ATRA - Uzoq muddatli majburiyatlarning kapitalga nisbati|InflaRx - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati X4 Pharmaceuticals Inc. XFOR|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|Celularity Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|INMB: Uzoq muddatli qarzning kapitalga nisbati|BRNS - Uzoq muddatli qarzdorlikning kapitalga nisbati|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics PLC (AKTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|BOLT (Bolt Biotherapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|ADTX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed Therapeutics (AFMD)|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati